The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, DocGo Inc’s stock clocked out at $4.33, up 1.88% from its previous closing price of $4.25. In other words, the price has increased by $1.88 from its previous closing price. On the day, 0.52 million shares were traded. DCGO stock price reached its highest trading level at $4.5 during the session, while it also had its lowest trading level at $4.32.
Ratios:
To gain a deeper understanding of DCGO’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.05. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.19. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $15.
On April 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
On April 19, 2022, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $11.Deutsche Bank initiated its Buy rating on April 19, 2022, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 14 ’24 when Burdiek Michael J bought 10,000 shares for $3.40 per share. The transaction valued at 34,000 led to the insider holds 581,595 shares of the business.
Tendler Ely D bought 10,000 shares of DCGO for $31,300 on May 13 ’24. The General Counsel and Secretary now owns 162,933 shares after completing the transaction at $3.13 per share. On May 13 ’24, another insider, Bienstock Lee, who serves as the Chief Executive Officer of the company, bought 25,000 shares for $3.15 each. As a result, the insider paid 78,750 and bolstered with 1,220,845 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 441880832 and an Enterprise Value of 409096672. As of this moment, DocGo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.96, and their Forward P/E ratio for the next fiscal year is 63.37. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.66 while its Price-to-Book (P/B) ratio in mrq is 1.36. Its current Enterprise Value per Revenue stands at 0.589 whereas that against EBITDA is 6.267.
Stock Price History:
Over the past 52 weeks, DCGO has reached a high of $6.20, while it has fallen to a 52-week low of $2.75. The 50-Day Moving Average of the stock is 21.53%, while the 200-Day Moving Average is calculated to be 24.83%.
Shares Statistics:
It appears that DCGO traded 520.30K shares on average per day over the past three months and 596310 shares per day over the past ten days. A total of 104.06M shares are outstanding, with a floating share count of 81.17M. Insiders hold about 20.46% of the company’s shares, while institutions hold 45.75% stake in the company. Shares short for DCGO as of 1730332800 were 7125066 with a Short Ratio of 13.69, compared to 1727654400 on 7559621. Therefore, it implies a Short% of Shares Outstanding of 7125066 and a Short% of Float of 7.08.
